The aim of this systematic review and meta-analysis was to conduct a comprehensive
assessment of the evidence on the efficacy and safety of oral dydrogesterone versus …

The pharmacological and physiological profiles of progestogens used for luteal phase
support during assisted reproductive technology are likely to be important in guiding clinical …

STUDY QUESTION Is oral dydrogesterone 30 mg daily (10 mg three times daily [TID]) non-
inferior to micronized vaginal progesterone (MVP) 600 mg daily (200 mg TID) for luteal …

STUDY QUESTION Is oral dydrogesterone 30 mg daily non-inferior to 8% micronized
vaginal progesterone (MVP) gel 90 mg daily for luteal phase support in IVF? SUMMARY …

Objectives To compare the effects of dydrogesterone and progesterone for luteal‐phase
support (LPS) in women undergoing assisted reproductive techniques (ART). Methods We …

Oral dydrogesterone has been used for luteal phase support on an empirical basis since the
early days of in vitro fertilization (IVF) treatment. Systematic comparisons of oral …

Statement of Retraction We, the Editors and Publisher of The Journal of Maternal-Fetal &
Neonatal Medicine, have retracted the following article: Alaa M. Ismail, Ahmed M. Abbas …

Objective To evaluate endocrine characteristics and clinical outcomes in normal ovulatory
patients undergoing controlled ovarian hyperstimulation (COH) with the use of a Duphaston …

Objective To identify, appraise, and summarize the evidence from randomized controlled
trials (RCTs) comparing oral dydrogesterone to vaginal progesterone capsules for luteal …

Objective To provide an evidence-based safety and tolerability overview of dydrogesterone
under various progesterone-deficient conditions as a commemoration of its role in managing …